Global Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Analysis by Product Type (Raw Materials, API), Service (Bioanalytical Testing, Stability Testing), End-User (Pharma Companies) and By Region (North America, Europe, Asia Pacific, Middle East and Africa and Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 - 2027

Report ID :AMI-530 | Category : Healthcare | Published Date : March, 2020 | Pages : 402 | Format :PDF

Industry Trends

Global pharmaceutical analytical testing outsourcing in healthcare market was valued at US$ 4602.86 million in 2018 and is anticipated to reach US$ 9930.59 million by 2027, growing at an estimated CAGR of 8.9% over the forecast period. Analytical testing is a vital portion in every phase of drug advancement and manufacturing. Like numerous other pharmaceutical, manufacturing and controlling activities, analytical testing is also regularly outsourced. Analytical testing helps in enabling real-time quality control along with optimizing and monitoring processes, describing biosimilars and biologics, and increases efficiency. The major reason for companies sending the work to outsourcing companies is the presence of experienced experts and to get hold of expensive analytical testing equipment’s which are commonly not available in-house.

As more multifaceted and vivid drugs enter the pipeline, it becomes critical for organisations to ensure that proper reliable, accurate and robust analytical methods are adopted to ensure proper quality and safety and that also adheres to strict timeline. Along with product development, analytical advancement is an incessant refining process, wherein products and procedure information accumulated at each expansion phase can be exploited to enhance the analytical approaches. This continuous upgradation approach is reinforced by strict regulatory norms: analytical approaches need to be equipped, but not authenticated until it reaches a particular phase. Once the analytical procedures are legalised, the FDA provides permission to be included throughout the life cycle of the product.

Analytical testing service is generally considered as a long-term project. On the service sponsor’s side, they are focusing more towards considering contract-based organisations as a tactical companion rather than temporary service provider. Analytical testing services are in favour of organisations that can provide integrated services, which permits them to cut the number of middle men, assist in modernising, and improving efficiency. Thus, the pharmaceutical analytical testing outsourcing in healthcare market witnessed a lucrative growth in the recent past and is anticipated to continue the same trend over the forecast period.

Rapid development of new products is a major factor driving the Pharmaceutical Analytical Testing Outsourcing in Healthcare Market. The prime reason is the rising focus on customized needs and advancement in technology which in turn reduces the life cycle of a product, which further leads to the outsourcing of the testing procedures to ensure implementation of the process within a limited time frame. Moreover, the introduction of combination products, biosimilars amongst others has led to a further upsurge in demand for some explicit class of analytical pharmaceutical procedures. Pharmaceutical analytical testing outsourcing services in healthcare has become a preferred service for many pharmaceutical companies due to its optimum efficiency, ability to satisfy the therapeutic needs and to acquire the expert services from on-demand services.

Pharmaceutical outsourcing companies have been investing heavily in the analytical testing. It has resulted in the lucrative growth of the market. Especially, in the research and development sector for the development of new products. For e.g. – companies such as Great Point, who is providing assistance to healthcare companies has invested more than $1.0 billion in healthcare companies since 2003, with most of the investment ranging between $7.0 and $25.0 million. Intertek Group plc, who is one of the global leader in providing laboratory outsourcing services and solutions has a huge research facility backed by huge investment put forward. Price benefits associated with outsourcing pharmaceutical analytical testing services and approvals have further resulted in the increasing demand for pharmaceutical analytical testing outsourcing in healthcare market. The major factor that restrains the growth of the market is the huge cost incurred in the drug development and quality inconsistencies in the drug is further limiting the pharmaceutical analytical testing outsourcing in healthcare market growth.

Service Insights

On the basis of services, bioanalytical testing held the major share in the pharmaceutical analytical testing outsourcing in healthcare market owing to the increasing number of clinical trials for new products. Clinical trials are research studies done by healthcare or pharmaceutical related individuals which aimed at assessing the medical or behavioural intervention. Clinical trial generally includes four main phases, starting from phase 1 trial, followed by phase two trial, phase three trial and phase four trial. Phase 1 trial tests an experimental conduct on a trivial group of healthy people (20 to 80) to critic its security and side effects and to identify the correct dosage. Phase two studies generally include more target groups and give more emphasis to the effectiveness on the drug compared to the safety side followed in the phase 1 trial. Phase three is much more of a detailed information regarding the safety and effectiveness and includes study with different people and different drug doses. And the number of people involved in the experiment is very high compared to the both the previous phases. In this trial, most important requisites are the FDA Approvals. If the FDA approves that the trial results are positive, it will announce the drug as the experimental drug or device. A Phase IV trial for drugs or devices is usually undertaken after the FDA approval. A device or drug's effectiveness and safety are monitored in large amongst diverse populations. Sometimes, the side effects of a drug may not be shown until people started taking it over a longer period of time. Clinical trials normally incurred more amount of time. For process like bioanalytical testing, it provides huge information to clinical studies to make it more appropriate and relevant. The advent of bioanalysis act as a vital means during the procedure of drug discovery and advancement of the drug. Over the past few decades, an excess of assays has been constantly established for NCEs (The National Counselor Examination for Licensure and Certification) to assist in the different stages of introduction and development. Additionally, multiple analytical trials are accessible for prescription medicines and generic products. Bioanalytical data formed in discovery and pre-clinical programs act as a trivial information to early clinical programs. Plasma concentration-response data acquired from these plans can be compared with human genes to understand whether any fluctuation is there or not.

Regional Insights

North America held the major share in the pharmaceutical analytical testing outsourcing in healthcare market owing to the presence of numerous pharmaceutical analytical testing outsourcing companies present in the region. For e.g. – Eurofins is one of the established biopharmaceutical outsourcing services partner focused on providing insights on pharmaceutical, biotechnology, cosmetic clients and medical device. The Group revolves around a whole chain of drug development to an international network of laboratories and testing units within global reach, uniform QA systems and high-quality services. One of the major trends in the region is the introduction of impurity solutions which is used as a stand-alone service in response to current regulatory norms and policies that set standards for the quantity of elemental impurities in drugs. Moreover, the United States pharmacopeial conventions (USP’s) requirement for controlling elemental impurities providing analytical methods and validation criteria was introduced in January 2018 for better monitoring of the drugs. The major analytical tests include potency studies, stability studies, method development and validation, compendia testing, compatibility studies, container closure testing and surface wipe sampling test. Compared to other companies, outsourcing companies provides an edge towards faster analytical response, better reliability, data safety, partnership development and lower cost. There are two types of outsourcing generally followed by the company, tactical and strategic outsourcing. Tactical outsourcing is generally a short-term solution towards complex situations, when a lab is overwhelmed by large volume or slow output. Strategics consulting, on the other hand, involves a long-term partnership that consists of decreased overhead costs and the ability to advance projects of lower priority.

Global Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue & Forecast, (US$ Million), 2015 – 2027

Competitive Landscape

Some of the players operating in the Pharmaceutical Analytical Testing Outsourcing in Healthcare Market are Toxikon, Inc.; Intertek Group PLC; SGS SA, Boston Analytical, Pace Analytical Services, LLC, West Pharmaceutical Services, Inc., WuXi AppTec, Inc., Pharmaceutical Product Development, LLC and Charles River Laboratories International, Inc amongst others.

Pharmaceutical Analytical Testing Outsourcing in Healthcare Market players are undertaking various strategic initiatives such as mergers, acquisitions, collaborations, and service portfolio as well as geographic expansion. For instance, in May 2019, Intertek announced the expansion of its pharmaceutical laboratory services in Melbourne, England. Moreover, in August 2019, Boston Analytical opened a new office in Cambridge, which provides analytical testing among other services, thereby expanding the reach of its services.

Click on image to enlarge

Global Pharmaceutical Analytical Testing Outsourcing in Healthcare Market:

Product type
- Raw Materials
- API
By Service
- Bioanalytical Testing
- Stability Testing
By Geography
- North America
  - US
  - Canada
  - Mexico
- Europe
  - France
  - The UK
  - Spain
  - Germany
  - Italy
  - Nordic Countries
  - Benelux Union
  - Rest of Europe
- Asia Pacific
  - China
  - Japan
  - India
  - New Zealand
  - Australia
  - South Korea
  - Southeast Asia
  - Rest of Asia Pacific
- Middle East and Africa
  - Saudi Arabia
  - UAE
  - Egypt
  - Kuwait
  - South Africa
  - Rest of Middle East & Africa
- Latin America
  - Brazil
  - Argentina
  - Rest of Latin America

Table of Contents

1. Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2015 - 2017

1.2.2. Base Year: 2018

1.2.3. Forecast Years: 2019 – 2027

2. Key Target Audiences

3. Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4. Recommendations and Insights from AMI’s Perspective**

5. Holistic Overview of Pharmaceutical Analytical Testing Outsourcing in Healthcare Market

6. Market Synopsis: Pharmaceutical Analytical Testing Outsourcing in Healthcare Market

7. Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.3. Trends in Pharmaceutical Analytical Testing Outsourcing in Healthcare Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: Pharmaceutical Analytical Testing Outsourcing in Healthcare Market

7.6. Porter’s Five Force Analysis

8. Global Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Analysis and Forecasts, 2019 – 2027

8.1. Overview

8.1.1. Global Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn)

8.2. Global Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

8.2.1. Raw Materials

8.2.1.1. Definition

8.2.1.2. Market Estimation and Penetration, 2015 – 2018

8.2.1.3. Market Forecast, 2019 – 2027

8.2.1.4. Compound Annual Growth Rate (CAGR)

8.2.1.5. Regional Bifurcation

8.2.1.5.1. North America

8.2.1.5.1.1. Market Estimation, 2015 – 2018

8.2.1.5.1.2. Market Forecast, 2019 – 2027

8.2.1.5.2. Europe

8.2.1.5.2.1. Market Estimation, 2015 – 2018

8.2.1.5.2.2. Market Forecast, 2019 – 2027

8.2.1.5.3. Asia Pacific

8.2.1.5.3.1. Market Estimation, 2015 – 2018

8.2.1.5.3.2. Market Forecast, 2019 – 2027

8.2.1.5.4. Middle East and Africa

8.2.1.5.4.1. Market Estimation, 2015 – 2018

8.2.1.5.4.2. Market Forecast, 2019 – 2027

8.2.1.5.5. Latin America

8.2.1.5.5.1. Market Estimation, 2015 – 2018

8.2.1.5.5.2. Market Forecast, 2019 – 2027

8.2.2. API

8.2.2.1. Definition

8.2.2.2. Market Estimation and Penetration, 2015 – 2018

8.2.2.3. Market Forecast, 2019 – 2027

8.2.2.4. Compound Annual Growth Rate (CAGR)

8.2.2.5. Regional Bifurcation

8.2.2.5.1. North America

8.2.2.5.1.1. Market Estimation, 2015 – 2018

8.2.2.5.1.2. Market Forecast, 2019 – 2027

8.2.2.5.2. Europe

8.2.2.5.2.1. Market Estimation, 2015 – 2018

8.2.2.5.2.2. Market Forecast, 2019 – 2027

8.2.2.5.3. Asia Pacific

8.2.2.5.3.1. Market Estimation, 2015 – 2018

8.2.2.5.3.2. Market Forecast, 2019 – 2027

8.2.2.5.4. Middle East and Africa

8.2.2.5.4.1. Market Estimation, 2015 – 2018

8.2.2.5.4.2. Market Forecast, 2019 – 2027

8.2.2.5.5. Latin America

8.2.2.5.5.1. Market Estimation, 2015 – 2018

8.2.2.5.5.2. Market Forecast, 2019 – 2027

8.3. Key Segment for Channeling Investments

8.3.1. By Product type

9. Global Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Analysis and Forecasts, 2019 – 2027

9.1. Overview

9.2. Global Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

9.2.1. Bioanalytical Testing

9.2.1.1. Definition

9.2.1.2. Market Estimation and Penetration, 2015 – 2018

9.2.1.3. Market Forecast, 2019 – 2027

9.2.1.4. Compound Annual Growth Rate (CAGR)

9.2.1.5. Regional Bifurcation

9.2.1.5.1. North America

9.2.1.5.1.1. Market Estimation, 2015 – 2018

9.2.1.5.1.2. Market Forecast, 2019 – 2027

9.2.1.5.2. Europe

9.2.1.5.2.1. Market Estimation, 2015 – 2018

9.2.1.5.2.2. Market Forecast, 2019 – 2027

9.2.1.5.3. Asia Pacific

9.2.1.5.3.1. Market Estimation, 2015 – 2018

9.2.1.5.3.2. Market Forecast, 2019 – 2027

9.2.1.5.4. Middle East and Africa

9.2.1.5.4.1. Market Estimation, 2015 – 2018

9.2.1.5.4.2. Market Forecast, 2019 – 2027

9.2.1.5.5. Latin America

9.2.1.5.5.1. Market Estimation, 2015 – 2018

9.2.1.5.5.2. Market Forecast, 2019 – 2027

9.2.2. Stability Testing

9.2.2.1. Definition

9.2.2.2. Market Estimation and Penetration, 2015 – 2018

9.2.2.3. Market Forecast, 2019 – 2027

9.2.2.4. Compound Annual Growth Rate (CAGR)

9.2.2.5. Regional Bifurcation

9.2.2.5.1. North America

9.2.2.5.1.1. Market Estimation, 2015 – 2018

9.2.2.5.1.2. Market Forecast, 2019 – 2027

9.2.2.5.2. Europe

9.2.2.5.2.1. Market Estimation, 2015 – 2018

9.2.2.5.2.2. Market Forecast, 2019 – 2027

9.2.2.5.3. Asia Pacific

9.2.2.5.3.1. Market Estimation, 2015 – 2018

9.2.2.5.3.2. Market Forecast, 2019 – 2027

9.2.2.5.4. Middle East and Africa

9.2.2.5.4.1. Market Estimation, 2015 – 2018

9.2.2.5.4.2. Market Forecast, 2019 – 2027

9.2.2.5.5. Latin America

9.2.2.5.5.1. Market Estimation, 2015 – 2018

9.2.2.5.5.2. Market Forecast, 2019 – 2027

9.3. Key Segment for Channeling Investments

9.3.1. By Service

10. North America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Analysis and Forecasts, 2019 - 2027

10.1. Overview

10.1.1. North America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn)

10.2. North America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

10.2.1. Raw Materials

10.2.2. API

10.3. North America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

10.3.1. Bioanalytical Testing

10.3.2. Stability Testing

10.4. North America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Country

10.4.1. U.S

10.4.1.1. U.S Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

10.4.1.1.1. Raw Materials

10.4.1.1.2. API

10.4.1.2. U.S Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

10.4.1.2.1. Bioanalytical Testing

10.4.1.2.2. Stability Testing

10.4.2. Canada

10.4.2.1. Canada Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

10.4.2.1.1. Raw Materials

10.4.2.1.2. API

10.4.2.2. Canada Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

10.4.2.2.1. Bioanalytical Testing

10.4.2.2.2. Stability Testing

10.4.3. Mexico

10.4.3.1. Mexico Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

10.4.3.1.1. Raw Materials

10.4.3.1.2. API

10.4.3.2. Mexico Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

10.4.3.2.1. Bioanalytical Testing

10.4.3.2.2. Stability Testing

10.4.4. Rest of North America

10.4.4.1. Rest of North America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

10.4.4.1.1. Raw Materials

10.4.4.1.2. API

10.4.4.2. Rest of North America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

10.4.4.2.1. Bioanalytical Testing

10.4.4.2.2. Stability Testing

10.5. Key Segment for Channeling Investments

10.5.1. By Country

10.5.2. By Product type

10.5.3. By Service

11. Europe Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Analysis and Forecasts, 2019 - 2027

11.1. Overview

11.1.1. Europe Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn)

11.2. Europe Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

11.2.1. Raw Materials

11.2.2. API

11.3. Europe Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

11.3.1. Bioanalytical Testing

11.3.2. Stability Testing

11.4. Europe Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Country

11.4.1. France

11.4.1.1. France Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

11.4.1.1.1. Raw Materials

11.4.1.1.2. API

11.4.1.2. France Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

11.4.1.2.1. Bioanalytical Testing

11.4.1.2.2. Stability Testing

11.4.2. The UK

11.4.2.1. The UK Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

11.4.2.1.1. Raw Materials

11.4.2.1.2. API

11.4.2.2. The UK Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

11.4.2.2.1. Bioanalytical Testing

11.4.2.2.2. Stability Testing

11.4.3. Spain

11.4.3.1. Spain Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

11.4.3.1.1. Raw Materials

11.4.3.1.2. API

11.4.3.2. Spain Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

11.4.3.2.1. Bioanalytical Testing

11.4.3.2.2. Stability Testing

11.4.4. Germany

11.4.4.1. Germany Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

11.4.4.1.1. Raw Materials

11.4.4.1.2. API

11.4.4.2. Germany Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

11.4.4.2.1. Bioanalytical Testing

11.4.4.2.2. Stability Testing

11.4.5. Italy

11.4.5.1. Italy Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

11.4.5.1.1. Raw Materials

11.4.5.1.2. API

11.4.5.2. Italy Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

11.4.5.2.1. Bioanalytical Testing

11.4.5.2.2. Stability Testing

11.4.6. Nordic Countries

11.4.6.1. Nordic Countries Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

11.4.6.1.1. Raw Materials

11.4.6.1.2. API

11.4.6.2. Nordic Countries Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

11.4.6.2.1. Bioanalytical Testing

11.4.6.2.2. Stability Testing

11.4.6.3. Nordic Countries Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Country

11.4.6.3.1. Denmark

11.4.6.3.2. Finland

11.4.6.3.3. Iceland

11.4.6.3.4. Sweden

11.4.6.3.5. Norway

11.4.7. Benelux Union

11.4.7.1. Benelux Union Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

11.4.7.1.1. Raw Materials

11.4.7.1.2. API

11.4.7.2. Benelux Union Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

11.4.7.2.1. Bioanalytical Testing

11.4.7.2.2. Stability Testing

11.4.7.3. Benelux Union Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Country

11.4.7.3.1. Belgium

11.4.7.3.2. The Netherlands

11.4.7.3.3. Luxembourg

11.4.8. Rest of Europe

11.4.8.1. Rest of Europe Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

11.4.8.1.1. Raw Materials

11.4.8.1.2. API

11.4.8.2. Rest of Europe Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

11.4.8.2.1. Bioanalytical Testing

11.4.8.2.2. Stability Testing

11.5. Key Segment for Channeling Investments

11.5.1. By Country

11.5.2. By Product type

11.5.3. By Service

12. Asia Pacific Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Analysis and Forecasts, 2019 - 2027

12.1. Overview

12.1.1. Asia Pacific Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn)

12.2. Asia Pacific Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

12.2.1. Raw Materials

12.2.2. API

12.3. Asia Pacific Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

12.3.1. Bioanalytical Testing

12.3.2. Stability Testing

12.4. Asia Pacific Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Country

12.4.1. China

12.4.1.1. China Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

12.4.1.1.1. Raw Materials

12.4.1.1.2. API

12.4.1.2. China Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

12.4.1.2.1. Bioanalytical Testing

12.4.1.2.2. Stability Testing

12.4.2. Japan

12.4.2.1. Japan Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

12.4.2.1.1. Raw Materials

12.4.2.1.2. API

12.4.2.2. Japan Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

12.4.2.2.1. Bioanalytical Testing

12.4.2.2.2. Stability Testing

12.4.3. India

12.4.3.1. India Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

12.4.3.1.1. Raw Materials

12.4.3.1.2. API

12.4.3.2. India Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

12.4.3.2.1. Bioanalytical Testing

12.4.3.2.2. Stability Testing

12.4.4. New Zealand

12.4.4.1. New Zealand Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

12.4.4.1.1. Raw Materials

12.4.4.1.2. API

12.4.4.2. New Zealand Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

12.4.4.2.1. Bioanalytical Testing

12.4.4.2.2. Stability Testing

12.4.5. Australia

12.4.5.1. Australia Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

12.4.5.1.1. Raw Materials

12.4.5.1.2. API

12.4.5.2. Australia Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

12.4.5.2.1. Bioanalytical Testing

12.4.5.2.2. Stability Testing

12.4.6. South Korea

12.4.6.1. South Korea Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

12.4.6.1.1. Raw Materials

12.4.6.1.2. API

12.4.6.2. South Korea Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

12.4.6.2.1. Bioanalytical Testing

12.4.6.2.2. Stability Testing

12.4.7. Southeast Asia

12.4.7.1. Southeast Asia Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

12.4.7.1.1. Raw Materials

12.4.7.1.2. API

12.4.7.2. Southeast Asia Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

12.4.7.2.1. Bioanalytical Testing

12.4.7.2.2. Stability Testing

12.4.7.3. Southeast Asia Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Country

12.4.7.3.1. Indonesia

12.4.7.3.2. Thailand

12.4.7.3.3. Malaysia

12.4.7.3.4. Singapore

12.4.7.3.5. Rest of Southeast Asia

12.4.8. Rest of Asia Pacific

12.4.8.1. Rest of Asia Pacific Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

12.4.8.1.1. Raw Materials

12.4.8.1.2. API

12.4.8.2. Rest of Asia Pacific Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

12.4.8.2.1. Bioanalytical Testing

12.4.8.2.2. Stability Testing

12.5. Key Segment for Channeling Investments

12.5.1. By Country

12.5.2. By Product type

12.5.3. By Service

13. Middle East and Africa Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Analysis and Forecasts, 2019 - 2027

13.1. Overview

13.1.1. Middle East and Africa Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn)

13.2. Middle East and Africa Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

13.2.1. Raw Materials

13.2.2. API

13.3. Middle East and Africa Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

13.3.1. Bioanalytical Testing

13.3.2. Stability Testing

13.4. Middle East and Africa Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Country

13.4.1. Saudi Arabia

13.4.1.1. Saudi Arabia Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

13.4.1.1.1. Raw Materials

13.4.1.1.2. API

13.4.1.2. Saudi Arabia Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

13.4.1.2.1. Bioanalytical Testing

13.4.1.2.2. Stability Testing

13.4.2. UAE

13.4.2.1. UAE Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

13.4.2.1.1. Raw Materials

13.4.2.1.2. API

13.4.2.2. UAE Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

13.4.2.2.1. Bioanalytical Testing

13.4.2.2.2. Stability Testing

13.4.3. Egypt

13.4.3.1. Egypt Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

13.4.3.1.1. Raw Materials

13.4.3.1.2. API

13.4.3.2. Egypt Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

13.4.3.2.1. Bioanalytical Testing

13.4.3.2.2. Stability Testing

13.4.4. Kuwait

13.4.4.1. Kuwait Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

13.4.4.1.1. Raw Materials

13.4.4.1.2. API

13.4.4.2. Kuwait Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

13.4.4.2.1. Bioanalytical Testing

13.4.4.2.2. Stability Testing

13.4.5. South Africa

13.4.5.1. South Africa Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

13.4.5.1.1. Raw Materials

13.4.5.1.2. API

13.4.5.2. South Africa Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

13.4.5.2.1. Bioanalytical Testing

13.4.5.2.2. Stability Testing

13.4.6. Rest of Middle East & Africa

13.4.6.1. Rest of Middle East & Africa Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

13.4.6.1.1. Raw Materials

13.4.6.1.2. API

13.4.6.2. Rest of Middle East & Africa Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

13.4.6.2.1. Bioanalytical Testing

13.4.6.2.2. Stability Testing

13.5. Key Segment for Channeling Investments

13.5.1. By Country

13.5.2. By Product type

13.5.3. By Service

14. Latin America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Analysis and Forecasts, 2019 - 2027

14.1. Overview

14.1.1. Latin America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn)

14.2. Latin America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

14.2.1. Raw Materials

14.2.2. API

14.3. Latin America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

14.3.1. Bioanalytical Testing

14.3.2. Stability Testing

14.4. Latin America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Country

14.4.1. Brazil

14.4.1.1. Brazil Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

14.4.1.1.1. Raw Materials

14.4.1.1.2. API

14.4.1.2. Brazil Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

14.4.1.2.1. Bioanalytical Testing

14.4.1.2.2. Stability Testing

14.4.2. Argentina

14.4.2.1. Argentina Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

14.4.2.1.1. Raw Materials

14.4.2.1.2. API

14.4.2.2. Argentina Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

14.4.2.2.1. Bioanalytical Testing

14.4.2.2.2. Stability Testing

14.4.3. Rest of Latin America

14.4.3.1. Rest of Latin America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type

14.4.3.1.1. Raw Materials

14.4.3.1.2. API

14.4.3.2. Rest of Latin America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$ Mn) and Forecasts, By Service

14.4.3.2.1. Bioanalytical Testing

14.4.3.2.2. Stability Testing

14.5. Key Segment for Channeling Investments

14.5.1. By Country

14.5.2. By Product type

14.5.3. By Service

15. Competitive Benchmarking

15.1. Market Share Analysis, 2018

15.2. Global Presence and Growth Strategies

15.2.1. Mergers and Acquisitions

15.2.2. Product Launches

15.2.3. Investments Trends

15.2.4. R&D Initiatives

16. Player Profiles

16.1. Boston Analytical

16.1.1. Company Details

16.1.2. Company Overview

16.1.3. Product Offerings

16.1.4. Key Developments

16.1.5. Financial Analysis

16.1.6. SWOT Analysis

16.1.7. Business Strategies

16.2. Charles River Laboratories International, Inc.

16.2.1. Company Details

16.2.2. Company Overview

16.2.3. Product Offerings

16.2.4. Key Developments

16.2.5. Financial Analysis

16.2.6. SWOT Analysis

16.2.7. Business Strategies

16.3. Eurofins Scientific

16.3.1. Company Details

16.3.2. Company Overview

16.3.3. Product Offerings

16.3.4. Key Developments

16.3.5. Financial Analysis

16.3.6. SWOT Analysis

16.3.7. Business Strategies

16.4. Intertek Group PLC

16.4.1. Company Details

16.4.2. Company Overview

16.4.3. Product Offerings

16.4.4. Key Developments

16.4.5. Financial Analysis

16.4.6. SWOT Analysis

16.4.7. Business Strategies

16.5. Pace Analytical Services, LLCs

16.5.1. Company Details

16.5.2. Company Overview

16.5.3. Product Offerings

16.5.4. Key Developments

16.5.5. Financial Analysis

16.5.6. SWOT Analysis

16.5.7. Business Strategies

16.6. Pharmaceutical Product Development, LLC

16.6.1. Company Details

16.6.2. Company Overview

16.6.3. Product Offerings

16.6.4. Key Developments

16.6.5. Financial Analysis

16.6.6. SWOT Analysis

16.6.7. Business Strategies

16.7. SGS SA

16.7.1. Company Details

16.7.2. Company Overview

16.7.3. Product Offerings

16.7.4. Key Developments

16.7.5. Financial Analysis

16.7.6. SWOT Analysis

16.7.7. Business Strategies

16.8. Toxikon, Inc

16.8.1. Company Details

16.8.2. Company Overview

16.8.3. Product Offerings

16.8.4. Key Developments

16.8.5. Financial Analysis

16.8.6. SWOT Analysis

16.8.7. Business Strategies

16.9. West Pharmaceutical Services, Inc

16.9.1. Company Details

16.9.2. Company Overview

16.9.3. Product Offerings

16.9.4. Key Developments

16.9.5. Financial Analysis

16.9.6. SWOT Analysis

16.9.7. Business Strategies

16.10. WuXi AppTec, Inc

16.10.1. Company Details

16.10.2. Company Overview

16.10.3. Product Offerings

16.10.4. Key Developments

16.10.5. Financial Analysis

16.10.6. SWOT Analysis

16.10.7. Business Strategies

16.11. Other market participants

Key FindingsNote: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

**Exclusive for Multi-User and Enterprise User.

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.

Prominent participants in our primary research process include:

Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

Reuters
Factiva
Bloomberg
One Source
Hoovers

Research Methodology

Key Inclusions

Request A Sample

Ask for Discount

Enquiry Before Buying

Request For Customization

Purchase Options

Single users $3300

Multi users $6600

Global users $7300

Buy Now

Reach to us

Call us on

+91-74002-42424

Drop us an email at

sales@absolutemarketsinsights.com